unknown
Stage
2013
Founded
3
Investors
About
Amylyx Pharmaceuticals develops therapies for neurodegenerative diseases, focusing on treatments that address ALS and other related disorders.
Explore Amylyx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.